 Myovant Sciences Ltd NYSE: MYOV shares are trading significantly lower Tuesday after the company and Pfizer Inc NYSE: PFE announced an update on the Supplemental New Drug Application for MYFEMBREE for the management of moderate to severe pain associated with endometriosis. In. 